(Q43037898)

English

IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1.

scientific article published on 13 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Staffan Nilsson

5

object named as

S Nilsson

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

M Lindh

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

B Arnholm

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

A Eilard

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

G Norkrans

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

J Söderholm

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

T Wahlberg

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

R Wejstål

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

J Westin

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

K Hellstrand

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

13 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

e325-31

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Triphasic decline of hepatitis C virus RNA during antiviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Viral kinetics in the treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Response Prediction and Treatment Tailoring for Chronic Hepatitis C Virus Genotype 1 Infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01425.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2010.01425.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

release_xihxawtngbgi5iutzowytvobnm

1 reference

https://api.fatcat.wiki/v0/release/xihxawtngbgi5iutzowytvobnm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43037898&oldid=1840239195"